Investor Risk is a topic tracked in our intelligence system with 5 linked articles.
Valar Atomics is reportedly seeking new funding at a $6B valuation, highlighting ongoing use of multi-stage rounds that can mask true entry prices.
Anthropic warns investors about secondary platforms not authorized to trade its shares, naming several firms.
Pro Max quota exhausted 5x in 1.5 hours despite moderate usage.
EU to appoint handler for a €5bn Scaleup Fund, with the fee structure yet to be decided.
Super Micro stock fell about 25% after the co-founder was charged in a $2.5B smuggling plot.
FDA intends to take action against non-FDA-approved GLP-1 drugs.
Subscribe for real-time topic updates and unlimited access to our intelligence platform.